Baotai Liang
Clinical trials sponsored by Baotai Liang, explained in plain language.
-
Experimental combo aims to tackle Hard-to-Treat prostate cancer
Disease control Recruiting nowThis phase 2 trial tests a combination of fasudil hydrochloride and an immunotherapy drug (tirapibep) in 30 men with metastatic castration-resistant prostate cancer that has progressed after standard treatments. Participants receive the drugs alongside standard hormone therapy ov…
Phase: PHASE2 • Sponsor: baotai Liang • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Triple-Drug attack before prostate surgery shows promise in early trial
Disease control Recruiting nowThis study tests whether adding two drugs—fasudil hydrochloride and a PD-1 inhibitor—to standard hormone therapy before prostate cancer surgery can better shrink or eliminate tumors. About 83 men with locally advanced or limited metastatic prostate cancer will receive either the …
Phase: PHASE2, PHASE3 • Sponsor: baotai Liang • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Could a traditional chinese medicine compound boost prostate cancer treatment?
Disease control Recruiting nowThis Phase 2 trial tests whether adding homoharringtonine (a drug from a Chinese evergreen plant) to standard hormone therapy before prostate removal can improve outcomes for men with high-risk or advanced prostate cancer. About 93 participants will receive the drug combination b…
Phase: PHASE2 • Sponsor: baotai Liang • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New combo therapy aims to wipe out prostate tumors before surgery
Disease control Recruiting nowThis Phase 2 trial tests whether adding homoharringtonine, a drug from a plant, to standard hormone therapy can better shrink or eliminate prostate cancer before surgery. About 96 men with locally advanced or limited spread prostate cancer will receive either the drug combo or a …
Phase: PHASE2 • Sponsor: baotai Liang • Aim: Disease control
Last updated Jun 26, 2026 14:51 UTC